Home Companies Janssen Biotech Page 2

Janssen Biotech

Latest

Infectious Diseases

StockWatch: Moderna’s Positive Phase III RSV Vaccine Data Wows Analysts

Immunology

StockWatch: Horizon Soars on Talks with Amgen, J&J, Sanofi

Conceptual illustration of neuron cells with glowing link knots. Synapse and neuron cells sending electrical chemical signals. Neuron of Interconnected neurons with electrical pulses, 3D illustration

Alzheimers

Jabbing at Alzheimer’s: AC Immune Takes Precision Approach to Vaccines

Musculoskeletal Disorders

Same Drug, New Partner: Capricor in Up-to-$735M Deal for DMD Cell Therapy

Janssen Biotech

FDA, CDC Urge Pause in J&J COVID-19 Vaccination, Citing “Rare” Blood Clots

Janssen Biotech

J&J Innovation Partners with AdoRx Therapeutics on Lung Cancer Treatments

Retinal Disease

Janssen Biotech

J&J’s Janssen to Develop MeiraGTx’s Retinal Disease Gene Therapies

Janssen Biotech

J&J/Janssen’s Cilag to Co-Develop argenx’s Cusatuzumab in $1.8B+ Collaboration

Janssen Biotech

Janssen Halts Clinical Studies of Alzheimer’s Candidate

Janssen Biotech

Vivus Buys U.S., Canada Rights to Pancreaze from Janssen for $135M

Janssen Biotech

Janssen to Codevelop Theravance’s TD-1473 in $1B+ Collaboration

Janssen Biotech

Janssen to Develop Bispecific Antibodies Based on Zymeworks Platforms in Up-to-$1.4B...

Janssen Biotech

J&J Halts Sirukumab Development, Talacotuzumab Trial

Janssen Biotech

Provention Bio to Develop Two Janssen GI Immunology Candidates

Janssen Biotech

J&J’s Janssen Halts Development of Hepatitis C Combo JNJ-4178, Citing Market...

123 Page 2 of 3